Abstract:Background: The objective of this study was to evaluate fluid-bed coating as a new technique to prepare a pellet-based solid self-nanoemulsifying drug delivery system (SNEDDS) using cyclosporin A as a model of a poorly water-soluble drug.Methods: The rationale of this technique was to entrap a Liquid SNEDDS in the matrix of the coating material, polyvinylpyrrolidone K30, by fluid-bed coating. Pseudoternary phase diagrams were used to screen the liquid SNEDDS formulations. The optimal formulation was composed of Labrafil M (R) 1944 CS, Transcutol P (R), and Cremophor (R) EL in a ratio of 9: 14:7. To prepare solid SNEDDS pellets, liquid SNEDDS was first dispersed in an aqueous solution of polyvinylpyrrolidone and then sprayed onto the surface of non-pareil pellets. Upon evaporation of water, polyvinylpyrrolidone precipitated and formed tight films to entrap the liquid SNEDDS. Visual observation and scanning electron microscopic analysis confirmed good appearance of the solid SNEDDS pellets.Results: Our results indicated that up to 40% of the liquid SNEDDS could be entrapped in the coating layer. Powder x-ray diffraction analysis confirmed nonexistence of crystalline cyclosporin A in the formulation. Solid SNEDDS pellets showed a slower redispersion rate than the liquid SNEDDS. An increase in the total liquid SNEDDS loading led to faster redispersion, whereas increased coating weight (up to 400%) significantly decreased the redispersion rate. Both cyclosporin A loading and protective coating with 5% polyvinylpyrrolidone K30 did not significantly affect the redispersion rate.Conclusion: It is concluded that fluid-bed coating is a new technique with considerable potential for preparation of pellet-based solid SNEDDS formulations.

Study on Preparation and Releasing Characteristics of Cyclosporin A Ph Sensitive Nanoparticles in Vitro

Two Novel Freeze-Dried Ph-Sensitive Cyclosporine A Nanoparticles: Preparation, in Vitro Drug Release, and in Vivo Absorption Enhancement Effects

Preparation of an Alternative Freeze-Dried Ph-Sensitive Cyclosporine A Loaded Nanoparticles Formulation and Its Pharmacokinetic Profile in Rats.

Studies on Preparation and Releasing of Cyclosporin A Liposome in Vitro

Studies on Preparation of Cyclosporine A-loaded Polycyanoacrylate Nanoparticles

Studies on in Vitro Release of Cyclosporine A-loaded Microspheres

[Preparation of Cyclosporine A Ph Sensitive Nanoparticles and Oral Pharmacokinetics in Rats].

Studies on Preparation of Cyclosporine A-Loaded Mixed Micelles and Its Physical-Chemical Properties

Long-term Studies on the Stability and Oral Bioavailability of Cyclosporine A Nanoparticle Colloid

Preparation and in Vitro Characterizations of Cyclosporine A Ocular Nanostructured Lipid Carriers

Preparation of Cyclosporine A -Loaded Cubic Nanoparticles and Determination of Encapsulation Efficiency

Preparation and in Vitro Release of Cyclosporine A Alginate Slow Release Microspheres

Ph-Sensitive Nanoparticles for Improving the Oral Bioavailability of Cyclosporine A.

Bioavailability and pharmacokinetics of cyclosporine A-loaded pH-sensitive nanoparticles for oral administration

Solid Self-Nanoemulsifying Cyclosporin A Pellets Prepared by Fluid-Bed Coating: Preparation, Characterization and in Vitro Redispersibility

Cyclosporine A-loaded albumin nanoparticles:preparation,in vitro release and evaluation of pharmacokinetics in rats

Preparation of Nanoparticles of Chitosan Loaded with Cyclosporine A and Distribution in the Eye

Preparation and Evaluation of Poly(Ethylene Glycol)–Poly(Lactide) Micelles As Nanocarriers for Oral Delivery of Cyclosporine A

Preparation and in Vitro Study of Solid Dispersions of Cyclosporine A

Preparation and in Vitro Evaluation of Saponins PD-loaded Eudragit L100 Nanoparticles

Sylysia 350/Eudragit S100 solid nanomatrix as a promising system for oral delivery of cyclosporine A.